Attention Bias Modification Treatment for Patients With Post Traumatic Stress Disorder (PTSD)
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
Patients with Post Traumatic Stress Disorder (PTSD) will be randomly assigned to either Attention Bias Modification Treatment (ABMT) designed to normalize threat-related attention biases or a placebo control condition not designed to change attention patterns. Outcome measures will be Post Traumatic Stress Disorder (PTSD), depression, and anxiety symptoms as measured by gold standard questionnaires and symptom counts derived from structured clinical interviews.
We expect to see significant Post Traumatic Stress Disorder symptom reduction in the Attention Bias Modification Treatment (ABMT) group relative to the placebo control group in which no symptomatic relief is expected.
| Condition | Intervention | Phase |
|---|---|---|
|
Attention Bias Modification Treatment (ABMT) |
Behavioral: Attention Bias Modification Treatment (ABMT) |
Phase 2 |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Intervention Model: Factorial Assignment Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor) Primary Purpose: Basic Science |
| Official Title: | Attention Bias Modification Treatment for Patients With Post Traumatic Stress Disorder (PTSD) |
- Clinician-Administered PTSD Scale (CAPS) [ Time Frame: 40 minutes ] [ Designated as safety issue: No ]The clinician-Administered PTSD Scale (CAPS) is a 30-item structured interview that corresponds to the DSM-IV criteria for PTSD (Blake, Weathers, Nagy, Kaloupek, Charney, & Keane, 1995).
- PTSD Check List (PCL) [ Time Frame: 10 minutes ] [ Designated as safety issue: No ]Post-traumatic Stress symptoms will be evaluated using the 17-item National Center for PTSD Checklist of the Department of Veterans Affairs- PCL (Blanchard, Jones-Alexander, Buckley, & Forneris, 1996; Hoge, 2004; Kang, Natelson, Mahan, Lee, & Murphy, 2003).
| Estimated Enrollment: | 100 |
| Study Start Date: | July 2011 |
| Estimated Study Completion Date: | December 2013 |
| Estimated Primary Completion Date: | December 2013 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
|---|---|
|
Experimental: Attention Bias Modification (ABM)
Attention training via repeated trials of a dot-probe task intended to normalize threat-related attention biases.
|
Behavioral: Attention Bias Modification Treatment (ABMT)
Attention training using a computerized spatial attention task (dot-probe) modified to alter threat-related attention patterns.
|
|
Placebo Comparator: Placebo
Attention training via repeated trials of a dot-probe task not intended to change threat-related attention patterns.
|
Behavioral: Attention Bias Modification Treatment (ABMT)
Attention training using a computerized spatial attention task (dot-probe) modified to alter threat-related attention patterns.
|
Eligibility| Genders Eligible for Study: | Male |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- Combat-related PTSD diagnosis
Exclusion Criteria:
- Other treatment
Contacts and Locations| Contact: Yair Bar-Haim, PhD | 972-3-6405465 | yair1@post.tau.ac.il |
| Contact: Reut Naim, MA | 972-54-6570555 | reutnaim@post.tau.ac.il |
| Israel | |
| Tel Aviv University | Recruiting |
| Tel Aviv, Israel, 69978 | |
| Principal Investigator: Yair Bar-Haim, PhD | |
| Principal Investigator: Eyal Fruchter, MD | |
More Information
Publications:
| Responsible Party: | Yair Bar-Haim, Professor, Tel Aviv University |
| ClinicalTrials.gov Identifier: | NCT01368302 History of Changes |
| Other Study ID Numbers: | 949-2010 |
| Study First Received: | May 31, 2011 |
| Last Updated: | December 29, 2011 |
| Health Authority: | Israel: Ministry of Health |
Keywords provided by Tel Aviv University:
|
attention bias modification treatment cognitive bias modification attention training anxiety |
Additional relevant MeSH terms:
|
Stress Disorders, Post-Traumatic Stress Disorders, Traumatic Anxiety Disorders Mental Disorders |
ClinicalTrials.gov processed this record on May 21, 2013